Aflac director Joseph Moskowitz sells stock for $106,790

Published 12/05/2025, 14:48
Aflac director Joseph Moskowitz sells stock for $106,790

Joseph L. Moskowitz, a director at Aflac Inc . (NYSE:AFL), a $56.7 billion insurance giant with a "GOOD" financial health score according to InvestingPro, has sold 1,000 shares of the company’s common stock, according to a recent SEC filing. The company stands out for its 41-year streak of dividend increases and recent positive earnings revisions from 4 analysts. The transaction, completed on May 8, was executed at a price of $106.79 per share, resulting in a total sale value of $106,790. Following this transaction, Moskowitz holds 26,096 shares of Aflac. Based on InvestingPro’s Fair Value analysis, the stock appears to be fairly valued, with 12 more exclusive insights available to subscribers, including detailed insider trading patterns and comprehensive valuation metrics.

The sale was conducted under a Rule 10b5-1 trading plan, which was adopted by Moskowitz on December 4, 2024. These plans allow insiders to set up a predetermined schedule for selling shares, providing a defense against potential accusations of insider trading. The stock has delivered a solid 25.7% return over the past year, maintaining its strong performance track record.

In other recent news, Aflac Incorporated reported its first-quarter 2025 earnings, revealing an adjusted earnings per share (EPS) of $1.66, which slightly missed the forecast of $1.68. The company’s revenue came in at $3.4 billion, significantly below the anticipated $4.26 billion, highlighting a notable revenue shortfall. In terms of regional performance, U.S. net earned premiums grew by 1.8%, while Japan experienced a 5% decline. Despite these challenges, Aflac demonstrated strong capital management by repurchasing $900 million in shares and launching new products in Japan to strengthen its market position.

Additionally, Aflac announced an expansion of its partnership with technology firm Empathy, integrating the LifeVault service into its group term life insurance offerings. This service aims to simplify legacy planning for users and will be available at no extra cost to eligible certificate holders starting July 1. In governance news, Aflac held its annual shareholder meeting, where 11 board members were elected, executive compensation was approved, and KPMG LLP was ratified as the independent auditor for the fiscal year ending December 31, 2025. These developments reflect Aflac’s ongoing strategic initiatives and governance practices.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.